Unlocking Precision Medicine: The Transformational Impact of CGP

Watch speakers from across the clinical spectrum to discuss the impact of genomic profiling to benefit cancer patients through precision therapies.

Topics covered include:

• The current and future state of genomics in driving precision oncology
• Role of comprehensive testing and biomarkers in driving treatment decisions
• Implementing comprehensive genomic profiling and its utility in healthcare system

Kevin Keegan
Vice President and General Manager, Oncology
Illumina

Phil Febbo, MD
Chief Medical Officer
Illumina

David Bartlett, MD
Chair
Allegheny Health Network (AHN) Cancer Institute

Sandip Patel, MD
Associate Professor of Medicine
University of California, San Diego

Rachel Sanborn, MD
Medical Oncologist
Earle A. Chiles Research Institute
Providence Cancer Institute